Prevagen May Have Memory Problems
TINA.org continues to support FTC, New York in federal court.
StemGenex
A false advertising class-action lawsuit was filed against StemGenex Medical Group in August 2016 and transferred to federal court in November 2016. The complaint alleges that the company misleadingly markets its Stem Cell Treatments will treat diseases – including Alzheimer’s, Parkinson’s, and multiple sclerosis – and 100% of its prior customers are satisfied with its service without a reasonable basis for making such claims. In addition, the complaint alleges that the company omits important information about its Stem Cell Treatments, including the dissatisfaction and complaints of ineffectiveness from customers. (Moorer et al v. StemGenex Medical Group, Inc. et al, Case No. 16-cv-2816, S. D. CA.)
The Latest
EasyPack
A bogus connection to major retailers is just the beginning.
My Passport Hub
Don’t pay for free online government forms.
Deception at the Cannes Lions Festival
Misleading campaigns highlight this year’s big ad event.
True Tone’s ‘Tan-Through’ Swimwear
Consumers may want to see through many of this company’s claims.